Search

T.H. v. Novartis

Ninety percent of the prescription drugs consumed in the United States are generic forms of brand-name drugs. But under U.S. Supreme Court case law, generic drug companies can’t be sued for failing to warn consumers of the dangers of their drug, no matter how inadequate...

‘Judicial Hellholes’: The Best Legal Joke of 2018

Here’s a good riddle: What do you call a court system that holds a drug manufacturer accountable for causing brain damage to children by failing to warn of its drug’s dangers? There are lots of good answers: Fair. Just. True to America's principles. The American Tort Reform Foundation’s answer is: “Judicial Hellhole #1.”

Public Justice Fights for Prescription Drug Victims in California Supreme Court

Generic drugs, anyone? If you care about access to justice, you might want to just say no. In a suit we've filed on behalf of twin boys, the California Supreme Court case will determine whether victims of inadequately labeled generic drugs can seek compensation for their injuries from brand-name drug manufacturers. The stakes couldn’t be higher: over 80 percent of all drugs consumed in this country are generic.

Public Justice Defends Rights of Generic Drug Victims in California Supreme Court

This case is a vivid example of why it’s important to allow lawsuits against brand-name drug companies for injuries caused by generic drugs. If the California Supreme Court lets Novartis off the hook, then the world will be a much more dangerous place.